Medical Devices Today

Radiation Oncology's TomoTherapy: Niche Player or Not?

Article preview from IN VIVO - June 2008

Radiation oncology is a very attractive market indeed. It's a $3 billion-plus capital equipment market predicted to experience a compound annual growth rate of 10 to 15% in the next several years, with the image-guided segment expected to grow at a 35% rate. Approximately 30% of the market is up for grabs over the next three years, as institutions replace old and obsolete equipment. Can small company TomoTherapy sustain the lead it has gained with a new image-guided system that increases the precision of cancer targeting and spares normal tissues, once entrenched multi-billion dollar radiation oncology companies begin to offer aggressive competition? Find out...

Health Care Trends: A New Way for Hospitals to Evaluate Technology

Article preview from Medtech Insight - May 2008

BONUS: Click here for immediate download of this full article from Medtech Insight

The rapid introduction of new medical technologies has created a wealth of tools and devices designed to improve patient care. But hospitals must decide which technologies from this dizzying array are worth purchasing based on their overall value to the organization. Find out why more and more hospitals are turning to outside sources to help them determine where to spend their dollars.

Mpathy Medical Devices Ltd.

Article preview from Start-Up - June 2008

Mpathy Medical Devices is focused on one of the hottest medtech markets--women's health. The company's physiologically compatible and ultra-lightweight Smartmesh technology targets the female anatomy to treat urinary stress incontinence and pelvic organ prolapse. Although Smartmesh is based on the same polypropylene material that has been used as mesh by other companies for many years for hernia repair and pelvic floor reconstruction, Mpathy Medical has innovated certain characteristics that encourage new tissue growth. Find out more.

Biomet: Device Maker Builds Second Production Base In China

Full Chinese-language news summary reprinted from PharmAsia News - July 28, 2008

Find out about U.S.-based medical device manufacturer Biomet's construction of its second production base in Changzhou High-tech District.

GE Healthcare: Exclusive Interview With New CEO John Dineen

Full interview reprinted from "The Gray Sheet" - July 28, 2008

While it seems like a big change, John Dineen suggests his recent move from chief exec of General Electric's locomotive and drilling equipment business to the top slot at the firm's healthcare unit is a natural transition. Find out what he has to say.

Boston Scientific: New Rhythm Management Chief Says It’s A New Day For Quality

Full article reprinted from "The Gray Sheet" - July 28, 2008

Find out why the new president of Boston Scientific's cardiac rhythm management division, Fred Colen, says the company's shift to a statistics-grounded quality control system allows the firm to prevent product component problems that might previously have been missed.

Need Help Planning Your Market Strategy In Europe?

Introducing the EU I.Q. European Surgical Procedures (ESP) Database Plus^TF: 2004-2009 from Medtech Insight

This unique database tracks both inpatient and outpatient surgeries performed in public, private and universities hospitals from five EU countries representing approximately 80% of the total European surgical market. Find out more.

GE Healthcare Buys Vital Signs For $990mm

This Week's Device Deals At-A-Glance repinted from Strategic Transactions - July 2008

GE Healthcare has agreed to buy Vital Signs (anesthesia, respiratory, sleep therapy, and emergency medicine single-patient use products) for $990mm or $74.50 in cash (a 27% premium) for each VS common share. Check out this week's other top deals.

Zimmer Hopes To Put Durom Hip Implant Suspension Behind It By Year-End

Full article reprinted from "The Gray Sheet" - July 28, 2008

Find out how Zimmer expects to update the labeling of its suspended Durom Cup metal-on-metal hip implant over the next several weeks, paving the way for a full reintroduction of the product into the U.S. market by 2009.

Artificial Discs: Experiencing a Cooling Trend

Article preview reprinted from IN VIVO - June 2008

BONUS: Click here for immediate download of this full nine-page article from IN VIVO

Even the larger players in the artificial disc market, including Johnson & Johnson's DePuy Inc., Medtronic Inc., Stryker Corp. and Synthes Inc. are not immune to the woes of the downturn. Find out why...